Physician profile
Daniel I Brison
NPI 1386808624
$6,168.77
in general payments reported to CMS, 2019-2025
27 companies · $1,678 in 2025
The $1,678 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $693 · 2020: $243 · 2021: $1,306 · 2022: $1,289 · 2023: $121 · 2024: $838 · 2025: $1,678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,503 · Travel and Lodging: $1,133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,503.44 |
| Travel and Lodging | $1,133.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,025.70 | 2022-2023 | Urolift |
| Edap Technomed INC | $764.99 | 2024-2025 | |
| Procept Biorobotics Corporation | $754.36 | 2021 | |
| Cook Incorporated | $730.05 | 2025 | Litho 150 |
| Cook Medical LLC | $642.02 | 2025 | Litho 150, S~Curve |
| Coloplast Corp | $414.37 | 2019-2022 | |
| Profound Medical Corp. | $357.72 | 2021-2022 | |
| Astellas Pharma US INC | $168.31 | 2019-2021 | |
| Pfizer INC. | $164.81 | 2019-2022 | |
| Medtronic, INC. | $151.40 | 2025 | Interstim |
| Medtronic USA, INC. | $148.35 | 2019 | |
| Boston Scientific Corporation | $144.62 | 2019-2024 | Upsylon, Bodyguardian |
| Neotract INC. | $123.51 | 2019 | |
| Allergan, INC. | $94.19 | 2019-2021 | |
| Abbvie INC. | $80.43 | 2024-2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $59.77 | 2023-2024 | Gemtesa |
| Progenics Pharmaceuticals, INC. | $50.00 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $47.67 | 2019-2020 | |
| Olympus America INC. | $44.80 | 2020-2022 | |
| Urovant Sciences INC | $41.83 | 2022 | |
| Ferring Pharmaceuticals INC. | $37.45 | 2025 | Adstiladrin |
| Laborie Medical Technologies Corp. | $33.18 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Urogen Pharma, INC. | $25.49 | 2022 | |
| Ambu INC. | $21.32 | 2023 | |
| Metuchen Pharmaceuticals | $16.91 | 2019 | |
| Acell, INC. | $12.96 | 2020 | |
| Avadel Specialty Pharmaceuticals, LLC | $12.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Brison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.